Last 27,200 KRW
Change Today -550.00 / -1.98%
Volume 85.4K
As of 10:45 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

ilyang pharmaceutical co ltd (007570) Snapshot

Open
28,050
Previous Close
27,750
Day High
28,150
Day Low
27,050
52 Week High
10/16/14 - 31,500
52 Week Low
08/13/14 - 22,450
Market Cap
486.8B
Average Volume 10 Days
120.3K
EPS TTM
--
Shares Outstanding
17.9M
EX-Date
03/28/14
P/E TM
--
Dividend
100.00
Dividend Yield
0.37%
Current Stock Chart for ILYANG PHARMACEUTICAL CO LTD (007570)

Related News

No related news articles were found.

ilyang pharmaceutical co ltd (007570) Related Businessweek News

No Related Businessweek News Found

ilyang pharmaceutical co ltd (007570) Details

Ilyang Pharamaceutical Co., Ltd. operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, Cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, digestive system, dermatology, infusion of nutrient, neurology, and respiratory system medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate(simaldrate), magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide(magcerin), synthetic aluminum silicate, and other products. Ilyang Pharamaceutical Co., Ltd. also exports pharmaceutical raw materials and finished products to 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharamaceutical Co., Ltd. in May 1991. Ilyang Pharamaceutical Co., Ltd. was founded in 1946 and is headquartered in Yongin, South Korea.

588 Employees
Last Reported Date: 11/14/13

ilyang pharmaceutical co ltd (007570) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ilyang pharmaceutical co ltd (007570) Key Developments

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 30, 2014

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 30, 2014., at 09:00 Korea Standard Time. Location: Headquarters Auditorium. Agenda: To consider audit reports, sales reports; to consider 43rd financial statements (including the statement of retained earnings) ended March 31, 2014; to consider the election of directors; to consider appointment of audit committee; and to consider the approval of director remuneration.

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 31, 2013

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 31, 2013., at 09:00 Tokyo Standard Time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
007570:KS 27,200.00 KRW -550.00

007570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 007570.
View Industry Companies
 

Industry Analysis

007570

Industry Average

Valuation 007570 Industry Range
Price/Earnings 100.0x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 219.3x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILYANG PHARMACEUTICAL CO LTD, please visit www.ilyang.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.